Médecins Sans Frontières welcomes the updated Global Action Plan on Antimicrobial Resistance and urges Member States to strengthen accountability mechanisms and match implementation with sustainable financing strategies, particularly for fragile and conflict-affected settings.
The Plan must tackle inequities in access to medical tools by closing access gaps in diagnostics and antibiotics, strengthening infection prevention, while monitoring availability, affordability, quality, and last-mile delivery. Access must be embedded in R&D financing, with public and philanthropic investments supporting timely, affordable access and stewardship-enabling delivery.
The GAP-AMR should strengthen laboratories and surveillance in fragile and conflict-affected settings, ensuring access to microbiology and fit-for-purpose diagnostics. It should also enable evidence generation where resistance occurs, so data inform policy, financing, and implementation, making access gaps and operational challenges visible and fundable.
